Literature DB >> 22232374

Molecular mechanisms underlying occult hepatitis B virus infection.

Jasmine Samal1, Manish Kandpal, Perumal Vivekanandan.   

Abstract

Chronic hepatitis B virus (HBV) infection is a complex clinical entity frequently associated with cirrhosis and hepatocellular carcinoma (HCC). The persistence of HBV genomes in the absence of detectable surface antigenemia is termed occult HBV infection. Mutations in the surface gene rendering HBsAg undetectable by commercial assays and inhibition of HBV by suppression of viral replication and viral proteins represent two fundamentally different mechanisms that lead to occult HBV infections. The molecular mechanisms underlying occult HBV infections, including recently identified mechanisms associated with the suppression of HBV replication and inhibition of HBV proteins, are reviewed in detail. The availability of highly sensitive molecular methods has led to increased detection of occult HBV infections in various clinical settings. The clinical relevance of occult HBV infection and the utility of appropriate diagnostic methods to detect occult HBV infection are discussed. The need for specific guidelines on the diagnosis and management of occult HBV infection is being increasingly recognized; the aspects of mechanistic studies that warrant further investigation are discussed in the final section.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22232374      PMCID: PMC3255968          DOI: 10.1128/CMR.00018-11

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  300 in total

1.  Identification of low HBV-DNA levels by nucleic acid amplification test (NAT) in blood donors.

Authors:  Stefano Dettori; Angela Candido; Loreta A Kondili; Paola Chionne; Stefania Taffon; Domenico Genovese; Paola Iudicone; Michelina Miceli; Maria Rapicetta
Journal:  J Infect       Date:  2009-06-18       Impact factor: 6.072

2.  Close monitoring of serum HBV DNA levels and liver enzymes levels is most useful in the management of patients with occult HBV infection.

Authors:  Isabelle Chemin; Olivier Guillaud; Philippe Chevallier Queyron; Christian Trépo
Journal:  J Hepatol       Date:  2009-06-25       Impact factor: 25.083

3.  Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function.

Authors:  Laura Belloni; Teresa Pollicino; Francesca De Nicola; Francesca Guerrieri; Giuseppina Raffa; Maurizio Fanciulli; Giovanni Raimondo; Massimo Levrero
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-11       Impact factor: 11.205

4.  Occult hepatitis B infection in patients infected with HIV: report of two cases of hepatitis B reactivation and prevalence in a hospital cohort.

Authors:  B Bloquel; H Jeulin; C Burty; L Letranchant; C Rabaud; V Venard
Journal:  J Med Virol       Date:  2010-02       Impact factor: 2.327

5.  Molecular characteristics of occult hepatitis B virus from blood donors in southeast China.

Authors:  Quan Yuan; Shan-Hai Ou; Chang-Rong Chen; Sheng-Xiang Ge; Bin Pei; Qing-Rui Chen; Qiang Yan; Yong-Cai Lin; Hong-Ying Ni; Cheng-Hao Huang; Anthony E T Yeo; James W K Shih; Jun Zhang; Ning-Shao Xia
Journal:  J Clin Microbiol       Date:  2009-11-25       Impact factor: 5.948

6.  Cytokine expression during chronic versus occult hepatitis B virus infection in HIV co-infected individuals.

Authors:  Christina M Martin; Jeffrey A Welge; Norah J Shire; Mohamed T Shata; Kenneth E Sherman; Jason T Blackard
Journal:  Cytokine       Date:  2009-07-21       Impact factor: 3.861

7.  Vitamin D receptor gene polymorphisms and distinct clinical phenotypes of hepatitis B carriers in Taiwan.

Authors:  Y-W Huang; Y-T Liao; W Chen; C-L Chen; J-T Hu; C-J Liu; M-Y Lai; P-J Chen; D-S Chen; S-S Yang; J-H Kao
Journal:  Genes Immun       Date:  2009-08-20       Impact factor: 2.676

8.  Blood donor screening with cobas s 201/cobas TaqScreen MPX under routine conditions at German Red Cross institutes.

Authors:  M Schmidt; L Pichl; C Jork; M K Hourfar; V Schottstedt; F F Wagner; E Seifried; T H Müller; J Bux; J Saldanha
Journal:  Vox Sang       Date:  2009-08-04       Impact factor: 2.144

9.  Association of exon 9 but not intron 8 VDR polymorphisms with occult HBV infection in south-eastern Iranian patients.

Authors:  Mohammad Kazemi Arababadi; Ali Akbar Pourfathollah; Abdollah Jafarzadeh; Gholamhossein Hassanshahi; Mohammad Ebrahim Rezvani
Journal:  J Gastroenterol Hepatol       Date:  2009-09-27       Impact factor: 4.029

10.  Reactivation of hepatitis B virus infection with persistently negative HBsAg on three HBsAg assays in a lymphoma patient undergoing chemotherapy.

Authors:  Wing-I Cheung; Henry Lik-Yuen Chan; Vincent King-Sun Leung; Chi-Hang Tse; Kitty Fung; Shek-Ying Lin; Ann Wong; Vincent Wai-Sun Wong; Tai-Nin Chau
Journal:  J Clin Virol       Date:  2009-12-23       Impact factor: 3.168

View more
  58 in total

Review 1.  Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs.

Authors:  Francesca De Nard; Monica Todoerti; Vittorio Grosso; Sara Monti; Silvia Breda; Silvia Rossi; Carlomaurizio Montecucco; Roberto Caporali
Journal:  World J Hepatol       Date:  2015-03-27

2.  Establishing the link between hepatitis B virus infection and colorectal adenoma.

Authors:  Brijesh B Patel; Seth Lipka; Huafeng Shen; Ashley H Davis-Yadley; Prakash Viswanathan
Journal:  J Gastrointest Oncol       Date:  2015-10

3.  Incidence and characteristics of HBV reactivation in hematological malignant patients in south Egypt.

Authors:  Abeer Elkady; Sahar Aboulfotuh; Elsayed Mostafa Ali; Douaa Sayed; Nashwa M Abdel-Aziz; Amany M Ali; Shuko Murakami; Sayuki Iijima; Yasuhito Tanaka
Journal:  World J Gastroenterol       Date:  2013-10-07       Impact factor: 5.742

4.  Occult infection related hepatitis B surface antigen variants showing lowered secretion capacity.

Authors:  Hong Kim; Seoung-Ae Lee; You-Sub Won; HyunJoo Lee; Bum-Joon Kim
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

Review 5.  Significance and Management of Isolated Hepatitis B Core Antibody (Anti-HBc) in HIV and HCV: Strategies in the DAA Era.

Authors:  Jennifer J Chang; Neaka Mohtashemi; Debika Bhattacharya
Journal:  Curr HIV/AIDS Rep       Date:  2018-04       Impact factor: 5.071

6.  Hepatitis B virus surface antigen (HBsAg)-positive and HBsAg-negative hepatitis B virus infection among mother-teenager pairs 13 years after neonatal hepatitis B virus vaccination.

Authors:  Qing-Qing Yao; Xiao-Lian Dong; Xue-Cai Wang; Sheng-Xiang Ge; An-Qun Hu; Hai-Yan Liu; Yueping Alex Wang; Quan Yuan; Ying-Jie Zheng
Journal:  Clin Vaccine Immunol       Date:  2012-12-19

Review 7.  Occult hepatitis B virus and hepatocellular carcinoma.

Authors:  Teresa Pollicino; Carlo Saitta
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

8.  High-throughput matrix-assisted laser desorption ionization-time of flight mass spectrometry as an alternative approach to monitoring drug resistance of hepatitis B virus.

Authors:  Magda Rybicka; Piotr Stalke; Marcin Dreczewski; Tomasz Smiatacz; Krzysztof Piotr Bielawski
Journal:  J Clin Microbiol       Date:  2013-09-25       Impact factor: 5.948

9.  Molecular characterization of hepatitis B virus X gene in HIV-positive South Africans.

Authors:  Maemu P Gededzha; Tsakani H Sondlane; Lesibana A Malinga; Rosemary J Burnett; Ramokone L Lebelo; Jason T Blackard; M Jeffrey Mphahlele; Selokela G Selabe
Journal:  Virus Genes       Date:  2018-02-06       Impact factor: 2.332

10.  Mutations in pre-core and basic core promoter regions of hepatitis B virus in chronic hepatitis B patients.

Authors:  Xiao-Ling Wang; Jian-Ping Ren; Xue-Qing Wang; Xiao-Hong Wang; Shao-Fang Yang; Yi Xiong
Journal:  World J Gastroenterol       Date:  2016-03-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.